244 related articles for article (PubMed ID: 15231440)
61. Evidence of a complete independence of the neurobiological substrates for the induction and expression of behavioral sensitization to amphetamine.
Cador M; Bjijou Y; Stinus L
Neuroscience; 1995 Mar; 65(2):385-95. PubMed ID: 7777156
[TBL] [Abstract][Full Text] [Related]
62. Electrophysiological effects of cocaine in the mesoaccumbens dopamine system: studies in the ventral tegmental area.
Einhorn LC; Johansen PA; White FJ
J Neurosci; 1988 Jan; 8(1):100-12. PubMed ID: 3339402
[TBL] [Abstract][Full Text] [Related]
63. Cocaine self-administration disrupts mesolimbic dopamine circuit function and attenuates dopaminergic responsiveness to cocaine.
Siciliano CA; Ferris MJ; Jones SR
Eur J Neurosci; 2015 Aug; 42(4):2091-6. PubMed ID: 26037018
[TBL] [Abstract][Full Text] [Related]
64. Activation of the cannabinoid system in the nucleus accumbens affects effort-based decision making.
Fatahi Z; Haghparast A
Pharmacol Biochem Behav; 2018 Feb; 165():29-35. PubMed ID: 29291421
[TBL] [Abstract][Full Text] [Related]
65. Intravenous self-administration of the cannabinoid CB1 receptor agonist WIN 55,212-2 in rats.
Fattore L; Cossu G; Martellotta CM; Fratta W
Psychopharmacology (Berl); 2001 Aug; 156(4):410-6. PubMed ID: 11498718
[TBL] [Abstract][Full Text] [Related]
66. Acute and repeated administration of the selective 5-HT(2A) receptor antagonist M100907 significantly alters the activity of midbrain dopamine neurons: an in vivo electrophysiological study.
Minabe Y; Hashimoto K; Watanabe KI; Ashby CR
Synapse; 2001 May; 40(2):102-12. PubMed ID: 11252021
[TBL] [Abstract][Full Text] [Related]
67. Bi-directional cannabinoid signalling in the basolateral amygdala controls rewarding and aversive emotional processing via functional regulation of the nucleus accumbens.
Ahmad T; Sun N; Lyons D; Laviolette SR
Addict Biol; 2017 Sep; 22(5):1218-1231. PubMed ID: 27230434
[TBL] [Abstract][Full Text] [Related]
68. A single exposure to morphine induces long-lasting behavioural and neurochemical sensitization in rats.
Vanderschuren LJ; De Vries TJ; Wardeh G; Hogenboom FA; Schoffelmeer AN
Eur J Neurosci; 2001 Nov; 14(9):1533-8. PubMed ID: 11722615
[TBL] [Abstract][Full Text] [Related]
69. Cannabinoid modulation of electrically evoked pH and oxygen transients in the nucleus accumbens of awake rats.
Cheer JF; Wassum KM; Wightman RM
J Neurochem; 2006 May; 97(4):1145-54. PubMed ID: 16686693
[TBL] [Abstract][Full Text] [Related]
70. Cannabinoids excite dopamine neurons in the ventral tegmentum and substantia nigra.
French ED; Dillon K; Wu X
Neuroreport; 1997 Feb; 8(3):649-52. PubMed ID: 9106740
[TBL] [Abstract][Full Text] [Related]
71. Effects of a cannabinoid agonist on spinal nociceptive neurons in a rodent model of neuropathic pain.
Liu C; Walker JM
J Neurophysiol; 2006 Dec; 96(6):2984-94. PubMed ID: 16943316
[TBL] [Abstract][Full Text] [Related]
72. Involvement of CB1 receptors in the ventral tegmental area in the potentiation of morphine rewarding properties in acquisition but not expression in the conditioned place preference model.
Rashidy-Pour A; Pahlevani P; Vaziri A; Shaigani P; Zarepour L; Vafaei AA; Haghparast A
Behav Brain Res; 2013 Jun; 247():259-67. PubMed ID: 23511249
[TBL] [Abstract][Full Text] [Related]
73. Differential effects of the sleep-inducing lipid oleamide and cannabinoids on the induction of long-term potentiation in the CA1 neurons of the rat hippocampus in vitro.
Lees G; Dougalis A
Brain Res; 2004 Jan; 997(1):1-14. PubMed ID: 14715144
[TBL] [Abstract][Full Text] [Related]
74. Cannabinoid Transmission in the Hippocampus Activates Nucleus Accumbens Neurons and Modulates Reward and Aversion-Related Emotional Salience.
Loureiro M; Kramar C; Renard J; Rosen LG; Laviolette SR
Biol Psychiatry; 2016 Aug; 80(3):216-25. PubMed ID: 26681496
[TBL] [Abstract][Full Text] [Related]
75. Repeated ventral tegmental area amphetamine administration alters dopamine D1 receptor signaling in the nucleus accumbens.
Hu XT; Koeltzow TE; Cooper DC; Robertson GS; White FJ; Vezina P
Synapse; 2002 Sep; 45(3):159-70. PubMed ID: 12112395
[TBL] [Abstract][Full Text] [Related]
76. Effects of ibogaine, and cocaine and morphine after ibogaine, on ventral tegmental dopamine neurons.
French ED; Dillon K; Ali SF
Life Sci; 1996; 59(12):PL199-205. PubMed ID: 8809219
[TBL] [Abstract][Full Text] [Related]
77. Prenatal ethanol exposure alters the postnatal development of the spontaneous electrical activity of dopamine neurons in the ventral tegmental area.
Choong K; Shen R
Neuroscience; 2004; 126(4):1083-91. PubMed ID: 15207341
[TBL] [Abstract][Full Text] [Related]
78. Cannabinoids modulate neuronal firing in the rat basolateral amygdala: evidence for CB1- and non-CB1-mediated actions.
Pistis M; Perra S; Pillolla G; Melis M; Gessa GL; Muntoni AL
Neuropharmacology; 2004 Jan; 46(1):115-25. PubMed ID: 14654103
[TBL] [Abstract][Full Text] [Related]
79. Inhibitory effect of cannabinoid agonists on gastric emptying in the rat.
Izzo AA; Mascolo N; Capasso R; Germanò MP; De Pasquale R; Capasso F
Naunyn Schmiedebergs Arch Pharmacol; 1999 Aug; 360(2):221-3. PubMed ID: 10494894
[TBL] [Abstract][Full Text] [Related]
80. Acute and repeated systemic amphetamine administration: effects on extracellular glutamate, aspartate, and serine levels in rat ventral tegmental area and nucleus accumbens.
Xue CJ; Ng JP; Li Y; Wolf ME
J Neurochem; 1996 Jul; 67(1):352-63. PubMed ID: 8667013
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
